Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ACCORD HLTHCARE

  • FDA Approval
  • Feb. 06, 2023, 12:40 UTC
  • 24
  • 0 comments

FDA approve OXYBUTYNIN CHLORIDE

Comment Full text

APOTEX INC

  • FDA Approval
  • Feb. 06, 2023, 12:40 UTC
  • 26
  • 0 comments

FDA approve ALBUTEROL SULFATE

Comment Full text

MANNKIND

  • FDA Approval
  • Feb. 06, 2023, 12:06 UTC
  • 24
  • 0 comments

FDA approve INSULIN RECOMBINANT HUMAN

Comment Full text

IMMUNOMEDICS INC

  • FDA Approval
  • Feb. 03, 2023, 19:41 UTC
  • 27
  • 0 comments

FDA approve SACITUZUMAB GOVITECAN-HZIY

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 03, 2023, 12:38 UTC
  • 28
  • 0 comments

FDA approve TOBRAMYCIN SULFATE

Comment Full text

HAINAN POLY

  • FDA Approval
  • Feb. 03, 2023, 12:38 UTC
  • 27
  • 0 comments

FDA approve ESOMEPRAZOLE SODIUM

Comment Full text

ZYDUS

  • FDA Approval
  • Feb. 03, 2023, 12:38 UTC
  • 27
  • 0 comments

FDA approve MACITENTAN

Comment Full text

GLAXOSMITHKLINE

  • FDA Approval
  • Feb. 02, 2023, 20:44 UTC
  • 27
  • 0 comments

FDA approve DAPRODUSTAT

Comment Full text

ACTELION

  • FDA Approval
  • Feb. 02, 2023, 20:37 UTC
  • 29
  • 0 comments

FDA approve MACITENTAN

Comment Full text

ASTRAZENECA AB

  • FDA Approval
  • Feb. 02, 2023, 20:34 UTC
  • 25
  • 0 comments

FDA approve TEZEPELUMAB-EKKO

Comment Full text
  • Previous
  • 889
  • 890
  • 891
  • 892
  • 893
  • Next

Search

News categories

  • Technical Exchange News(12239)
  • Event(6229)
  • SEC News(265126)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(154672)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin